Molecular dynamics and high throughput binding free energy calculation of anti-actin anticancer drugs-New insights for better design
Related Experiment Video
Updated: Mar 20, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Roopa L1, Pravin Kumar R2, Sudheer Mohammed M M3
1Research and Development Centre, Bharathiar University, Coimbatore, India; Department of Biotechnology, Mount Carmel College, Bangalore, India.
Abstract:
Actin cytoskeleton plays an important role in cancerous cell progression. Till date many anticancer toxins are discovered that binds to different sites of actin. Mechanism of action of these toxins varies with respect to the site where they bind to actin. Latrunculin A (LAT) binds closely to nucleotide binding site and Reidispongiolide binds to the barbed end of actin. LAT is reported to reduce the displacement of domain 2 with respect to domain 1 and allosterically modulate nucleotide exchange. On the other hand Reidispongiolide binds with the higher affinity to actin and competes with the DNaseI binding loop once the inter-monomer interaction has been formed. Evolving better actin binders being the aim of this study we conducted a comparative molecular dynamics of these two actin-drug complexes and actin complexed with ATP alone, 50ns each. High throughput binding free energy calculations in conjugation with the high-throughput MD simulations was used to predict modifications in these two renowned anti-actin anticancer drugs for better design. Per residue energy profiling that contribute to free energy of binding shows that there is an unfavourable energy at the site where Asp157 interacts with 2-thiazolidinone moiety of LAT. Similarly, unfavourable energies are reported near macrocyclic region of Reidispongiolide specifically near carbons 7, 11 & 25 and tail region carbons 27 & 30. These predicted sites can be used for modifications and few of these are discussed in this work based on the interactions with the binding site residues. The study reveals specific interactions that are involved in the allosteric modulation of ATP by these two compounds. Glu207 closely interacting with LAT A initiates the allosteric effect on ATP binding site specifically affecting residues Asp184, Lys215 and Lys336. RGA bound actin shows high anti-correlated motions between sub domain 3 and 4. Unlike LAT A, Reidispongiolide induces a flat structure of actin which definitely should affect actin polymerisation and lead to disassembly of actin filaments.
Insights
This study compares how Latrunculin A and Reidispongiolide bind to actin, revealing key interactions for designing improved anticancer drugs that target the actin cytoskeleton.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The actin cytoskeleton is crucial for cancer progression.
- Various anticancer toxins target actin, with distinct binding sites and mechanisms.
- Latrunculin A (LAT) and Reidispongiolide (RGA) are examples of actin-binding anticancer agents.
Purpose of the Study:
- To comparatively analyze the molecular dynamics of actin-drug complexes with LAT and RGA.
- To predict potential modifications for enhancing the efficacy of these actin binders.
- To elucidate the specific interactions governing allosteric modulation of ATP binding.
Main Methods:
- Comparative molecular dynamics (MD) simulations of actin-drug complexes (50ns each).
- High-throughput binding free energy calculations.
- Per-residue energy profiling to identify key interaction sites.
Main Results:
- Unfavorable energy sites identified for LAT (Asp157 interaction) and RGA (macrocyclic and tail regions).
- Specific interactions mediating allosteric modulation of ATP by LAT (Glu207) and RGA were revealed.
- RGA induces anti-correlated motions and a flattened actin structure, impacting polymerization.
Conclusions:
- Identified specific residues and regions on actin crucial for LAT and RGA binding and allosteric modulation.
- These findings provide a basis for rational drug design of novel actin-targeting anticancer agents.
- Understanding these interactions is key to developing more effective therapies against cancer.
More Related Videos
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Related Concept Videos
The Equilibrium Binding Constant and Binding Strength
Actin Polymerization
The nucleation phase involves forming a stable nucleus consisting of three actin monomers to form a new actin filament. Actin-binding proteins such as formins and Arp2/3 complex help filament growth post-nucleation. The Formins form straight...
Introduction to Actin
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...